Abstract
High-risk metastatic neuroblastoma tumors have a poor prognosis even after aggressive multimodal therapeutic protocols. Retinoic Acid (RA) treatments were included in these multimodal therapies because its ability to induce differentiation of neuroblastoma cells in vitro and it appears to reduce the risk of tumor recurrence as established in a large multicentre clinical assay. The present article deals with the molecular actions of RA on neuroblastoma cells. We want to discuss novel actions of RA at the post-transcriptional level (alternative splicing, translational control of specific mRNAs, microRNA regulation) that in addition to the well-characterized actions of RA at the transcriptional level contribute to neuroblastoma cell differentiation. We propose that RA acts coordinately over the multiple regulatory layers of gene expression and therefore must be considered as a global regulator of gene expression in neuroblastoma cells.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Alam AH, Suzuki H, Tsukahara T (2010) Retinoic acid treatment and cell aggregation independently regulate alternative splicing in P19 cells during neural differentiation. Cell Biol Int 34:631ā643
Altucci L, Rossin A, Hirsch O, Nebbioso A, Vitoux D, Wilhelm E, Guidez F, De Simone M, Schiavone EM, Grimwade D, Zelent A, de The H, Gronemeyer H (2005) Rexinoid-triggered differentiation and tumor-selective apoptosis of acute myeloid leukemia by protein kinase A-mediated desubordination of retinoid X receptor. Cancer Res 65:8754ā8765
Apostolatos H, Apostolatos A, Vickers T, Watson JE, Song S, Vale F, Cooper DR, Sanchez-Ramos J, Patel NA (2010) Vitamin A metabolite, all-trans-retinoic acid, mediates alternative splicing of protein kinase C deltaVIII (PKCdeltaVIII) isoform via splicing factor SC35. J Biol Chem 285:25987ā25995
Auboeuf D, Honig A, Berget SM, OāMalley BW (2002) Coordinate regulation of transcription and splicing by steroid receptor coregulators. Science 298:416ā419
Auboeuf D, Dowhan DH, Kang YK, Larkin K, Lee JW, Berget SM, OāMalley BW (2004) Differential recruitment of nuclear receptor coactivators may determine alternative RNA splice site choice in target genes. Proc Natl Acad Sci U S A 101:2270ā2274
Auboeuf D, Batsche E, Dutertre M, Muchardt C, OāMalley BW (2007) Coregulators: transducing signal from transcription to alternative splicing. Trends Endocrinol Metab 18:122ā129
Bartel DP (2009) MicroRNAs: target recognition and regulatory functions. Cell 136:215ā233
Boutz PL, Stoilov P, Li Q, Lin CH, Chawla G, Ostrow K, Shiue L, Ares M Jr, Black DL (2007) A post-transcriptional regulatory switch in polypyrimidine tract-binding proteins reprograms alternative splicing in developing neurons. Genes Dev 21:1636ā1652
Bruck N, Vitoux D, Ferry C, Duong V, Bauer A, de The H, Rochette-Egly C (2009) A coordinated phosphorylation cascade initiated by p38MAPK/MSK1 directs RARalpha to target promoters. EMBO J 28:34ā47
Calarco JA, Superina S, OāHanlon D, Gabut M, Raj B, Pan Q, Skalska U, Clarke L, Gelinas D, van der Kooy D, Zhen M, Ciruna B, Blencowe BJ (2009) Regulation of vertebrate nervous system alternative splicing and development by an SR-related protein. Cell 138:898ā910
Chekulaeva M, Filipowicz W (2009) Mechanisms of miRNA-mediated post-transcriptional regulation in animal cells. Curr Opin Cell Biol 21:452ā460
Chen JD, Evans RM (1995) A transcriptional co-repressor that interacts with nuclear hormone receptors. Nature 377:454ā457
Coutinho-Mansfield GC, Xue Y, Zhang Y, Fu XD (2007) PTB/nPTB switch: a post-transcriptional mechanism for programming neuronal differentiation. Genes Dev 21:1573ā1577
De Preter K, Mestdagh P, Vermeulen J, Zeka F, Naranjo A, Bray I, Castel V, Chen C, Drozynska E, Eggert A, Hogarty MD, Izycka-Swieszewska E, London WB, Noguera R, Piqueras M, Bryan K, Schowe B, van Sluis P, Molenaar JJ, Schramm A, Schulte JH, Stallings RL, Versteeg R, Laureys G, Van Roy N, Speleman F, Vandesompele J (2011) miRNA expression profiling enables risk stratification in archived and fresh neuroblastoma tumor samples. Clin Cancer Res 17:7684ā7692
Duong V, Rochette-Egly C (2011) The molecular physiology of nuclear retinoic acid receptors. From health to disease. Biochim Biophys Acta 1812:1023ā1031
Escamilla JM, BƤuerl C, LĆ³pez CMR, Pekkala SP, Navarro S, Barettino D (2012) Retinoic-acid-induced downregulation of the 67 KDa laminin receptor correlates with reduced biological aggressiveness of human neuroblastoma cells. In: Shimada H (ed) Neuroblastoma-present and future. InTech Open Access Publisher, Manhattan, NY, USA pp 217ā232
Foley NH, Bray I, Watters KM, Das S, Bryan K, Bernas T, Prehn JH, Stallings RL (2011) MicroRNAs 10a and 10b are potent inducers of neuroblastoma cell differentiation through targeting of nuclear receptor corepressor 2. Cell Death Differ 18:1089ā1098
Hammes SR, Levin ER (2007) Extranuclear steroid receptors: nature and actions. Endocr Rev 28:726ā741
Jensen KB, Dredge BK, Stefani G, Zhong R, Buckanovich RJ, Okano HJ, Yang YY, Darnell RB (2000) Nova-1 regulates neuron-specific alternative splicing and is essential for neuronal viability. Neuron 25:359ā371
Laserna EJ, Valero ML, Sanz L, del Pino MM, Calvete JJ, Barettino D (2009) Proteomic analysis of phosphorylated nuclear proteins underscores novel roles for rapid actions of retinoic acid in the regulation of mRNA splicing and translation. Mol Endocrinol 23:1799ā1814
Lau P, Hudson LD (2010) MicroRNAs in neural cell differentiation. Brain Res 1338:14ā19
Long JC, Caceres JF (2009) The SR protein family of splicing factors: master regulators of gene expression. Biochem J 417:15ā27
Lopez-Carballo G, Moreno L, Masia S, Perez P, Barettino D (2002) Activation of the phosphatidylinositol 3-kinase/Akt signaling pathway by retinoic acid is required for neural differentiation of SH-SY5Y human neuroblastoma cells. J Biol Chem 277:25297ā25304
Lovat F, Valeri N, Croce CM (2011) MicroRNAs in the pathogenesis of cancer. Semin Oncol 38:724ā733
Ma L, Teruya-Feldstein J, Weinberg RA (2007) Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature 449:682ā688
Maris JM (2010) Recent advances in neuroblastoma. N Engl J Med 362:2202ā2211
Mark M, Ghyselinck NB, Chambon P (2009) Function of retinoic acid receptors during embryonic development. Nucl Recept Signal 7:e002
Masia S, Alvarez S, de Lera AR, Barettino D (2007) Rapid, nongenomic actions of retinoic acid on phosphatidylinositol-3-kinase signaling pathway mediated by the retinoic acid receptor. Mol Endocrinol 21:2391ā2402
Matthay KK, Villablanca JG, Seeger RC, Stram DO, Harris RE, Ramsay NK, Swift P, Shimada H, Black CT, Brodeur GM, Gerbing RB, Reynolds CP (1999) Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis- retinoic acid. Childrenās Cancer Group. N Engl J Med 341:1165ā1173
Matthay KK, Reynolds CP, Seeger RC, Shimada H, Adkins ES, Haas-Kogan D, Gerbing RB, London WB, Villablanca JG (2009) Long-term results for children with high-risk neuroblastoma treated on a randomized trial of myeloablative therapy followed by 13-cis-retinoic acid: a childrenās oncology group study. J Clin Oncol 27:1007ā1013
Meseguer S, Mudduluru G, Escamilla JM, Allgayer H, Barettino D (2011) MicroRNAs-10a and -10b contribute to retinoic acid-induced differentiation of neuroblastoma cells and target the alternative Splicing Regulatory Factor SFRS1 (SF2/ASF). J Biol Chem 286:4150ā4164
Michlewski G, Sanford JR, Caceres JF (2008) The splicing factor SF2/ASF regulates translation initiation by enhancing phosphorylation of 4E-BP1. Mol Cell 30:179ā189
Miska EA, Alvarez-Saavedra E, Townsend M, Yoshii A, Sestan N, Rakic P, Constantine-Paton M, Horvitz HR (2004) Microarray analysis of microRNA expression in the developing mammalian brain. Genome Biol 5:R68
Moriarty CH, Pursell B, Mercurio AM (2010) miR-10b targets Tiam1: implications for Rac activation and carcinoma migration. J Biol Chem 285:20541ā20546
Pahlman S, Ruusala AI, Abrahamsson L, Mattsson ME, Esscher T (1984) Retinoic acid-induced differentiation of cultured human neuroblastoma cells: a comparison with phorbolester-induced differentiation. Cell Differ 14:135ā144
Piskunov A, Rochette-Egly C (2011) A retinoic acid receptor RARalpha pool present in membrane lipid rafts forms complexes with G protein alphaQ to activate p38MAPK. Oncogene 31:3333ā3345
Sanford JR, Gray NK, Beckmann K, Caceres JF (2004) A novel role for shuttling SR proteins in mRNA translation. Genes Dev 18:755ā768
Stallings RL (2009) MicroRNA involvement in the pathogenesis of neuroblastoma: potential for microRNA mediated therapeutics. Curr Pharm Des 15:456ā462
Stamm S (2008) Regulation of alternative splicing by reversible protein phosphorylation. J Biol Chem 283:1223ā1227
Theodosiou M, Laudet V, Schubert M (2010) From carrot to clinic: an overview of the retinoic acid signaling pathway. Cell Mol Life Sci 67:1423ā1445
Underwood JG, Boutz PL, Dougherty JD, Stoilov P, Black DL (2005) Homologues of the Caenorhabditis elegans Fox-1 protein are neuronal splicing regulators in mammals. Mol Cell Biol 25:10005ā10016
Veerla S, Lindgren D, Kvist A, Frigyesi A, Staaf J, Persson H, Liedberg F, Chebil G, Gudjonsson S, Borg A, Mansson W, Rovira C, Hoglund M (2009) MiRNA expression in urothelial carcinomas: important roles of miR-10a, miR-222, miR-125b, miR-7 and miR-452 for tumor stage and metastasis, and frequent homozygous losses of miR-31. Int J Cancer 124:2236ā2242
Vicent GP, Ballare C, Nacht AS, Clausell J, Subtil-Rodriguez A, Quiles I, Jordan A, Beato M (2006) Induction of progesterone target genes requires activation of Erk and Msk kinases and phosphorylation of histone H3. Mol Cell 24:367ā381
Voigt A, Zintl F (2003) Effects of retinoic acid on proliferation, apoptosis, cytotoxicity, migration, and invasion of neuroblastoma cells. Med Pediatr Oncol 40:205ā213
Wakamatsu A, Imai J, Watanabe S, Isogai T (2010) Alternative splicing of genes during neuronal differentiation of NT2 pluripotential human embryonal carcinoma cells. FEBS Lett 584:4041ā4047
Weiss FU, Marques IJ, Woltering JM, Vlecken DH, Aghdassi A, Partecke LI, Heidecke CD, Lerch MM, Bagowski CP (2009) Retinoic acid receptor antagonists inhibit miR-10a expression and block metastatic behavior of pancreatic cancer. Gastroenterology 137(2136ā2145):e2131āe2137
Xiao SH, Manley JL (1997) Phosphorylation of the ASF/SF2 RS domain affects both protein-protein and protein-RNA interactions and is necessary for splicing. Genes Dev 11:334ā344
Zhong XY, Wang P, Han J, Rosenfeld MG, Fu XD (2009) SR proteins in vertical integration of gene expression from transcription to RNA processing to translation. Mol Cell 35:1ā10
Acknowledgements
The research work described in this article was financed through grants of the Spanish National Plan for Research, Development and Innovation (SAF2003-00311, SAF2006-00647, SAF2007-60780, and SAF2010-15032), Generalitat Valenciana (ACOMP 09/212) and Genoma EspaƱa to D. Barettino. S. Meseguer was the recipient of an EACR training and travel fellowship award and a CSIC I3P predoctoral fellowship/contract. E. J. Laserna was the recipient of a pre-doctoral fellowship/contract (FPI) from ConsellerĆa de EducaciĆ³n y Ciencia de la Generalitat Valenciana (Spain). S. MasiĆ” was supported by a pre-doctoral fellowship (FPI) from the former Ministry of Science and Technology and a contract from Programa de ContrataciĆ³n de TĆ©cnicos, former Ministry of Education and Science.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
Ā© 2013 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Meseguer, S., Laserna, E.J., Escamilla, J.M., MasiĆ”, S., Barettino, D. (2013). Regulation of Neuroblastoma Cell Differentiation by Retinoic Acid: Role of Alternative Splicing and micro-RNAs. In: Hayat, M. (eds) Pediatric Cancer, Volume 4. Pediatric Cancer, vol 4. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-6591-7_5
Download citation
DOI: https://doi.org/10.1007/978-94-007-6591-7_5
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-007-6590-0
Online ISBN: 978-94-007-6591-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)